newest glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists GLP-1 Receptor Agonists as Treatments

Yet the context in which these therapies are prescribed has diverged sharply

3 There are currently three PBS-subsidised GLP-1RAs dulaglutide, exenatide and semaglutide with different administration frequencies and devices

10.1111/dom.13761 Summary Keywords anti-inflammatory, atherosclerosis, coronary artery disease, glucagon-like peptide-1, mechanisms Citation Skrobucha A, Pindlowski P, Krajewska N, Grabowski M and Jonik S (2024) Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review

102,103 Albiglutide is a long-acting GLP-1RA injected subcutaneously once a week

& Zhao, B

A randomized controlled trial involving 26 healthy adults showed that allulose consumption (5g) significantly reduced after-meal glucose spikes compared to sucrose controls